Clinical Trial Update: TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

View source ↗

Summary

The TRACK-MSA longitudinal study, sponsored by NYU Langone Health, has completed and aims to define outcome measures for Multiple System Atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple System Atrophy | Status: COMPLETED